Gerresheimer
Axel Herberg is a seasoned executive and investor with extensive experience in the healthcare and manufacturing sectors. Currently, Axel serves as a Member of the Supervisory Board at EHC European Healthcare Acquisition and Growth Company and holds the position of Private Investor at CCC Investment GmbH since November 2010. Additionally, Axel is a member of the Advisory Board at Vetter Pharma and has been the Chairman of the Supervisory Board at Gerresheimer since 2015. Previously, Axel acted as Vice Chairman of the Supervisory Board at Leica Camera AG until April 2022 and worked as a Senior Advisor and Senior Managing Director at The Blackstone Group until January 2019. Axel's earlier roles included Group CEO at Gerresheimer AG from 1992 to 2010, Consultant at McKinsey & Company from 1988 to 1992, and Strategic Planning at ThyssenKrupp from 1986 to 1988.
This person is not in any teams
This person is not in any offices
Gerresheimer
1 followers
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.